Why is Krebs Biochem falling/rising?

As of 20-Jun, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 84.11, which represents a decrease of 2.39 or 2.76%. The stock has been underperforming significantly, having fallen consecutively for the last four days, resulting in a total decline of 12.99% during this period. Additionally, the stock's performance over the past week shows a decrease of 5.17%, while it has generated a return of 15.85% over the last year, which is notably higher than the market's return of 2.60%. However, the company has reported negative results for the last two consecutive quarters, with a negative book value and a high debt-to-equity ratio, indicating weak long-term fundamental strength. This combination of factors has contributed to the stock's recent downward movement.
In the broader market context, Krebs Biochem's short-term performance contrasts sharply with the benchmark Sensex, which has increased by 1.59% over the past week. While the stock has shown some positive returns over the past month at 11.82%, its year-to-date performance is down 9.07%, highlighting a struggle against a backdrop of overall market growth, as indicated by the Sensex's 5.46% increase. The falling investor participation, as evidenced by a significant drop in delivery volume, further suggests a lack of confidence among investors, which is likely exacerbating the stock's decline amidst a generally positive market environment.